Medical Marijuana, Inc. (OTC: MJNA) reported $20.7 million in revenue for the second quarter ending June 30, 2019, an increase of 30 percent over $15.8 million in Q2 2018.
“We are excited to continue our tremendous sequential success with the second quarter of 2019 proving to be the largest sales revenue quarter in the history of our company,” said Dr. Stuart Titus, chief executive officer of Medical Marijuana, Inc. “As the world continues to become more receptive to learning about the benefits of hemp-derived CBD, we are enthusiastic about being at the forefront of the global cannabis industry.”
According to the company, second quarter sales growth reflects the company’s international and domestic expansion into all sales channels, including direct-to-consumer, wholesale and direct selling channels.
“We hope that these impressive results excite our valued shareholders and look forward to providing more transparency and accountability moving forward,” said Medical Marijuana, Inc. COO Blake Schroeder. “Our number one priority is profitability and we are not only reaching our quarterly goals for this but are surpassing them.”
To view Medical Marijuana, Inc.’s Q2 2019 press release, click here.
